Skip to content

Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD)

Evaluation of Tissue Perfusion in Patients With Lower Extremity Peripheral Arterial Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05570019
Acronym
EVTI-PAD
Enrollment
200
Registered
2022-10-06
Start date
2022-10-01
Completion date
2024-12-31
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Limb-Threatening Ischemia, Critical Limb Ischemia, Peripheral Arterial Disease

Keywords

Tissue perfusion, Peripheral arterial disease, Critical limb threatening ischemia, Critical limb ischemia, Fluorescence angiography, Fluorescence imaging, Indocyanine green, Microcirculation

Brief summary

In this prospective single-center observational study, arterial perfusion in patients with lower limb peripheral arterial disease will be assessed with standard diagnostic tools (toe pressure, trans-cutaneous oxygen pressure, ankle-brachial index and fluorescence angiography) before and after standard revascularization procedures (open surgery and/or angioplasty).

Detailed description

Arterial perfusion is an important parameter for the capacity of wound healing in patients with peripheral arterial disease (PAD). Quantifying tissue perfusion in affected patients can help in deciding whether further revascularization is necessary to achieve wound healing and limb salvage. Not only in PAD patients with ulceration, but also in patients with rest pain or life-style limiting claudication, the measurement of arterial perfusion before and after revascularization could influence further treatment regarding surgical/interventional procedures as well as medical treatment. Digital subtraction angiography (DSA) is the gold standard for the evaluation of peripheral arterial outflow and for quality assessment after revascularization. However, angiography only displays the larger arteries and not tissue perfusion itself, which is crucial for wound healing. In this study, the change of tissue perfusion measured with the different standard diagnostic tools (toe pressure, trans-cutaneous oxygen pressure, ankle-brachial index and fluorescence angiography) before and after standard revascularization procedures will be evaluated.

Interventions

PROCEDURERevascularization

Open surgery (arterial endarterectomy with or without bypass surgery) and/or angioplasty (with or without stent placement)

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- patients with symptomatic peripheral arterial disease (Rutherford categories 3-6) requiring revascularization.

Exclusion criteria

* patients younger than 18 years * patients unable to give consent without legal guardians * iodine allergy * hyperthyroidism * allergy to indocyanine green * Glomerular filtration rate \<30ml/min/1.73m2

Design outcomes

Primary

MeasureTime frameDescription
Transcutaneous oxygen pressurePre-procedural, post-procedural (within 5 days) and 3 months after the index procedureChange in transcutaneous oxygen pressure is measured before and after the revascularization procedure.

Secondary

MeasureTime frameDescription
Rutherford categoryPre-procedural, post-procedural (within 5 days) and 3 months after the index procedureChange in Rutherford category is documented before and after the revascularization procedure.
Primary patencyPost-procedural (within 5 days) and 3 months after the index procedurePrimary patency of the treated arterial lesion is documented after the procedure
Secondary patencyPost-procedural (within 5 days) and 3 months after the index procedureSecondary patency of the treated arterial lesion is documented after the procedure
WIfI stagePre-procedural, post-procedural (within 5 days) and 3 months after the index procedureChange in WIfI (wound, ischemia, foot infection) stage is documented before and after the revascularization procedure.
Ankle-brachial index (ABI)Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedureChange in ABI is documented before and after the revascularization procedure.
Fluorescence angiographyPre-procedural, post-procedural (within 5 days) and 3 months after the index procedureChange in fluorescence angiography is documented before and after the revascularization procedure.
SurvivalPost-procedural (within 5 days) and 3 months after the index procedureSurvival of patients after the revascularization.
Limb salvagePost-procedural (within 5 days) and 3 months after the index procedureLimb salvage of the treated extremity is documented after the procedure

Countries

Austria

Contacts

Primary ContactFlorian K Enzmann, MD, PhD
florian.enzmann@i-med.ac.at004343512504
Backup ContactMichaela Kluckner, MD
michaela.kluckner@i-med.ac.at004343512504

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026